Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Xtant Medical Holdings (XTNT) Net Cash Flow (2016 - 2025)

Xtant Medical Holdings has reported Net Cash Flow over the past 16 years, most recently at $3.5 million for Q3 2025.

Quarterly Net Cash Flow rose 121.8% to $3.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, up 874.72% year-over-year, with the annual reading at $447000.0 for FY2024, 103.06% up from the prior year.
Net Cash Flow was $3.5 million for Q3 2025 at Xtant Medical Holdings, up from $1.6 million in the prior quarter.
Over five years, Net Cash Flow peaked at $16.3 million in Q1 2021 and troughed at -$15.1 million in Q1 2023.
The 5-year median for Net Cash Flow is -$124000.0 (2022), against an average of $440105.3.
Year-over-year, Net Cash Flow surged 1379.3% in 2022 and then plummeted 966.17% in 2023.
A 5-year view of Net Cash Flow shows it stood at -$227000.0 in 2021, then surged by 1379.3% to $2.9 million in 2022, then plummeted by 199.97% to -$2.9 million in 2023, then skyrocketed by 73.96% to -$756000.0 in 2024, then surged by 565.61% to $3.5 million in 2025.
Per Business Quant, the three most recent readings for XTNT's Net Cash Flow are $3.5 million (Q3 2025), $1.6 million (Q2 2025), and -$784000.0 (Q1 2025).